Dengue - Sample Collection Study Pakistan

A Prospective Study for the Collection of Whole Blood Samples to Support the Development and Validation of In Vitro Diagnostic Tests for Dengue

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07203183

Enrollment

200

Registered

2025-10-02

Start date

2025-10-01

Completion date

2026-04-01

Last updated

2025-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dengue

Keywords

dengue, sample collection, serum, plasma, blood

Brief summary

The objective of this study is to collect well-characterized serum and plasma specimens from confirmed dengue positive and dengue negative subjects to support dengue diagnostic products development.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

12 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Age ≥12-years-old * Individuals suspected or confirmed for active dengue, with dengue-consistent symptoms onset up to and including 10 days before enrolment in this trial.

Exclusion criteria

* Subject has been vaccinated for dengue. * Subject participates in an investigative drug, vaccine or medical device clinical study * Participant is deemed unfit for the study by the Investigator * Participant is unwilling or unable to provide informed consent

Design outcomes

Primary

Measure	Time frame
sample collection only, no specific outcome needed	5 months

Contacts

Primary ContactSimon Kordowich, PHD

info@abbott.com+353 (0)91 429 900

Backup ContactJocelyn Farge, MSc, MBA